MBCI 0.00 MabCure, Inc.
| Range: | 1.0E-6-0.009 | Vol Avg: | 561 | Last Div: | 0 | Changes: | 0 |
| Beta: | 8.49 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Energy | IPO: | Wed Dec 05 2007 | Empoloyees: | 3 | ||
| CUSIP: | 554094102 | CIK: | ISIN: | US5540941029 | Country: | US | |
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow